Yep, efficacy will definitely bring world-wide attention to this humble little stock that right now is quietly hidden away in the world's most remote city, and with it a MC that will be many, many multiples of where it sits currently.
Triple this you say Zac? I would suggest waaay beyond triple if efficacy is shown myself.
As the board of AGN put it, Proving the neuroprotective ability of ARG-007 will be a significant derisking milestone for the Company and opportunity to place Argenica at the forefront of neuroprotective clinical validation.
Yep, efficacy will definitely bring world-wide attention to this...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.0¢ |
Change
0.005(0.64%) |
Mkt cap ! $101.3M | |||
| Open | High | Low | Value | Volume |
| 79.8¢ | 79.8¢ | 79.0¢ | $1.007K | 1.269K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10361 | 79.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 3994 | 2 |
View Market Depth
| Last trade - 15.15pm 11/09/2024 (20 minute delay) ? |
| AGN (ASX) Chart |